Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lynne A. Bui, MD
Exelixis
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Medical Center
Los Angeles, California, United States
- Peachtree Hematology Oncology Consultants
Atlanta, Georgia, United States
- Wayne State University, Karmanos Cancer Institute
Detroit, Michigan, United States
- Hematology-Oncology Associates of Rockland
Nyack, New York, United States
- Cancer Therapy and Research Center at the Ut Health Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2007
- Primary completion
- 31 Jan 2008
- Completion
- 31 May 2008
- Last update posted
- 19 Feb 2010
- Registered enrollment
- 2
- Registry id
- NCT00491699
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.